vimarsana.com
  1. Home
  2. Live Updates
  3. Company Expanded Access Program - Breaking News

Page 11 - Company Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RedHill Biopharma Closes $8 0 Million Underwritten Public Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of an.

New yorkUnited statesRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programSyndicate departmentAegis capital corpBusiness developmentHill biopharmaAmerican depositary sharePrivate securities litigation reform actExpanded access programAnnual report

RedHill Biopharma Closes $8 0 Million Underwritten Public Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the closing of an.

New yorkUnited statesRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programSyndicate departmentAegis capital corpBusiness developmentHill biopharmaAmerican depositary sharePrivate securities litigation reform actExpanded access programAnnual report

RedHill Biopharma Prices $8 0 Million Underwritten Public Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the pricing of an.

New yorkUnited statesRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programSyndicate departmentAegis capital corpBusiness developmentHill biopharmaAmerican depositary sharePrivate securities litigation reform actExpanded access programAnnual report

RedHill Biopharma Announces Proposed Public Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it intends to.

New yorkUnited statesRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programSyndicate departmentAegis capital corpBusiness developmentAmerican depositary sharesHill biopharmaPrivate securities litigation reform actExpanded access programAnnual report

RedHill Biopharma Announces Proposed Public Offering

/PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it intends to.

New yorkUnited statesRedhill biopharmaAdi frishRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programSyndicate departmentAegis capital corpBusiness developmentAmerican depositary sharesHill biopharmaPrivate securities litigation reform actExpanded access programAnnual report

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.